JP2010505848A5 - - Google Patents

Download PDF

Info

Publication number
JP2010505848A5
JP2010505848A5 JP2009531464A JP2009531464A JP2010505848A5 JP 2010505848 A5 JP2010505848 A5 JP 2010505848A5 JP 2009531464 A JP2009531464 A JP 2009531464A JP 2009531464 A JP2009531464 A JP 2009531464A JP 2010505848 A5 JP2010505848 A5 JP 2010505848A5
Authority
JP
Japan
Prior art keywords
mrs
intraocular pressure
eye
administering
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009531464A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010505848A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/021409 external-priority patent/WO2008045330A2/en
Publication of JP2010505848A publication Critical patent/JP2010505848A/ja
Publication of JP2010505848A5 publication Critical patent/JP2010505848A5/ja
Pending legal-status Critical Current

Links

Images

JP2009531464A 2006-10-06 2007-10-05 眼内圧を低下させるための種交差性ａ３アデノシン受容体アンタゴニストの効果的送達 Pending JP2010505848A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85017506P 2006-10-06 2006-10-06
PCT/US2007/021409 WO2008045330A2 (en) 2006-10-06 2007-10-05 Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure

Publications (2)

Publication Number Publication Date
JP2010505848A JP2010505848A (ja) 2010-02-25
JP2010505848A5 true JP2010505848A5 (https=) 2010-11-25

Family

ID=39283379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009531464A Pending JP2010505848A (ja) 2006-10-06 2007-10-05 眼内圧を低下させるための種交差性ａ３アデノシン受容体アンタゴニストの効果的送達

Country Status (8)

Country Link
US (1) US20090258836A1 (https=)
EP (1) EP2076267A4 (https=)
JP (1) JP2010505848A (https=)
AU (1) AU2007307157A1 (https=)
BR (1) BRPI0715318A2 (https=)
CA (1) CA2665616A1 (https=)
MX (1) MX2009003750A (https=)
WO (1) WO2008045330A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG182285A1 (en) 2010-01-11 2012-08-30 Inotek Pharmaceuticals Corp Combination, kit and method of reducing intraocular pressure
EA201290958A1 (ru) * 2010-03-26 2013-04-30 Инотек Фармасьютикалз Корпорейшн Способ снижения внутриглазного давления у людей с применением n6-циклопентиладенозина (cpa), производных cpa или их пролекарств
BR112014018413A8 (pt) 2012-01-26 2017-07-11 Inotek Pharmaceuticals Corp Polimorfos anidros de nitrato de metila [(2r,3s,4r,5r)-5-(6-(ciclopentilamino)-9h-purin-9-il)-3,4-diidroxitetraidrofuran-2-il)] e processos de preparação do mesmo
CA2903114A1 (en) 2013-03-15 2014-09-25 Inotek Pharmaceuticals Corporation Ophthalmic formulations
ES2578363B1 (es) 2015-01-22 2017-01-31 Palobiofarma, S.L. Moduladores de los receptores A3 de adenosina
HK1254892A1 (zh) 2016-01-14 2019-08-02 韩德株式会社 拮抗a3腺苷受体的化合物、其制备方法、及其医学用途
ES2676535B1 (es) 2017-01-20 2019-04-29 Palobiofarma Sl Moduladores de los receptores a3 de adenosina
KR101805400B1 (ko) 2017-03-21 2017-12-07 퓨쳐메디신 주식회사 아데노신 유도체를 포함하는 녹내장 예방 및 치료용 약학적 조성물
CN109666053A (zh) * 2017-10-16 2019-04-23 张家口华健致远生物科技有限公司 一种a3腺苷受体激动剂及其用途
KR102007640B1 (ko) * 2017-11-29 2019-08-07 퓨쳐메디신 주식회사 아데노신 유도체를 포함하는 망막 질환 또는 시신경 질환 예방 및 치료용 약학적 조성물
US11395597B2 (en) * 2018-06-26 2022-07-26 General Electric Company System and method for evaluating blood flow in a vessel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2244774C (en) * 1996-01-29 2006-10-17 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists
ATE290910T1 (de) * 1998-07-16 2005-04-15 Univ Pennsylvania Verwendung von a3-adenosine antagonisten zur herstellung eines arzneimittels zur senkung des augeninnendrucks
IL133680A0 (en) * 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

Similar Documents

Publication Publication Date Title
JP2010505848A5 (https=)
AU2006234627C1 (en) Therapeutic agent for dyskinesia
US12006328B2 (en) Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto
RU2470635C2 (ru) Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза
WO2008045330A3 (en) Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure
PT1511481E (pt) Utilização oftalmológica de roflumilast para o tratamento de doenças do olho
WO2017106306A1 (en) Methods of treating hyperalgesia
KR20070005911A (ko) 개선된 비-진정성 알파-2 효능제의 신규 동정 방법
EP2525793B1 (en) Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect
AU2023201678B2 (en) Methods for the use of 5'-adenosine diphosphate ribose (ADPR)
WO2008016016A1 (fr) Préparation liquide aqueuse contenant un amide
JP2013500977A5 (https=)
KR102723194B1 (ko) Cftr 조절제 및 이의 사용 방법
CN1143321A (zh) 用5-ht2拮抗剂治疗观念与行为强迫症的方法
JP2005535564A (ja) 緑内障または高眼圧症の治療のための組成物および方法
CN102822188A (zh) 腺苷化合物及其用途
JP4308255B2 (ja) ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤
JP6832336B2 (ja) アルコール乱用の治療におけるγ−ヒドロキシ酪酸の選択されたアミドおよびその使用
US20250353861A1 (en) Derivative of artemisinin and preparation method and use thereof
WO2012125400A1 (en) Compositions and methods using adenosine a3 receptor antagonists for the treatment of inflammatory eye diseases
JP2002020279A (ja) 点眼液
KR20240134157A (ko) 파킨슨 치료제의 개선된 코 투여
AU2021433515B2 (en) Prodrug of celecoxib, preparation method therefor and application thereof
JP2009500398A5 (https=)
JP2009500397A5 (https=)